Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Patient/Physician Matching System: Physicians

The NAABT Patient /Physician Matching System is a centralized list of patients from which certified physicians, in your area, can draw from when they have an opening. It is a more efficient way to help connect patient to physician. more
Register Detailed Instructions Frequently Asked Questions

Returning Physician Sign-In


Secure • Confidential
I forgot my password.

Intended Use

The intent of this site is to efficiently connect patients in need of treatment for opioid dependence with an Office based treatment provider, certified to prescribe buprenorphine. It is unlawful to use this site to solicit for anything other then stated above. Example: it is inconsistent with the terms to use this site to solicit for “Rapid detox”,“inpatient rehab”, or any other treatment that is not considered Office based opioid dependence treatment with buprenorphine, and such treatment must be consistent with the physician training established to obtain the DEA waiver to prescribe schedule III medications, for opioid dependence, in an office based setting, according to the DATA2000 law. If you do not have an “X” number from the DEA you are not authorized to use this application.
(see additional terms here)
This page was last modified on : 12/24/2009
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.